Biomarkers, tissue, genetics | Class | References |
---|---|---|
Genetic testing should be considered in several inherited arrhythmic diseases associated with an increased risk of ventricular arrhythmia and SCD. | 95–97 | |
MRI with LGE to detect fibrosis and scar may be useful in assessing the risk of arrhythmic events in AF patients and patients with cardiomyopathies. | 98–100 | |
Plasma NT-proBNP may be useful in differentiating patients with higher vs. lower burden of AF. | 101–105 | |
Plasma CRP or other inflammatory markers may be useful in risk assessment, for identifying individuals with increased risk of future AF and for identifying individuals with high degree of atrial fibrosis. | 106–108 |